vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Metallus Inc. (MTUS). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $267.3M, roughly 1.0× Metallus Inc.). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -5.3%, a 6.1% gap on every dollar of revenue. On growth, Metallus Inc. posted the faster year-over-year revenue change (11.1% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-37.2M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

HCM vs MTUS — Head-to-Head

Bigger by revenue
HCM
HCM
1.0× larger
HCM
$270.8M
$267.3M
MTUS
Growing faster (revenue YoY)
MTUS
MTUS
+27.7% gap
MTUS
11.1%
-16.5%
HCM
Higher net margin
HCM
HCM
6.1% more per $
HCM
0.7%
-5.3%
MTUS
More free cash flow
HCM
HCM
$40.6M more FCF
HCM
$3.4M
$-37.2M
MTUS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
MTUS
MTUS
Revenue
$270.8M
$267.3M
Net Profit
$2.0M
$-14.3M
Gross Margin
37.7%
2.2%
Operating Margin
-13.2%
-7.7%
Net Margin
0.7%
-5.3%
Revenue YoY
-16.5%
11.1%
Net Profit YoY
-83.6%
33.2%
EPS (diluted)
$0.00
$-0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
MTUS
MTUS
Q4 25
$270.8M
$267.3M
Q3 25
$305.9M
Q2 25
$277.7M
$304.6M
Q1 25
$324.5M
$280.5M
Q4 24
$240.5M
Q3 24
$227.2M
Q2 24
$305.7M
$294.7M
Q1 24
$321.6M
Net Profit
HCM
HCM
MTUS
MTUS
Q4 25
$2.0M
$-14.3M
Q3 25
$8.1M
Q2 25
$455.0M
$3.7M
Q1 25
$11.9M
$1.3M
Q4 24
$-21.4M
Q3 24
$-5.9M
Q2 24
$25.8M
$4.6M
Q1 24
$24.0M
Gross Margin
HCM
HCM
MTUS
MTUS
Q4 25
37.7%
2.2%
Q3 25
11.4%
Q2 25
0.1%
10.6%
Q1 25
48.0%
7.8%
Q4 24
4.5%
Q3 24
5.3%
Q2 24
41.1%
8.2%
Q1 24
15.7%
Operating Margin
HCM
HCM
MTUS
MTUS
Q4 25
-13.2%
-7.7%
Q3 25
3.6%
Q2 25
-1.3%
2.8%
Q1 25
-5.0%
1.0%
Q4 24
-10.1%
Q3 24
-3.1%
Q2 24
-9.0%
2.1%
Q1 24
9.3%
Net Margin
HCM
HCM
MTUS
MTUS
Q4 25
0.7%
-5.3%
Q3 25
2.6%
Q2 25
163.8%
1.2%
Q1 25
3.7%
0.5%
Q4 24
-8.9%
Q3 24
-2.6%
Q2 24
8.4%
1.6%
Q1 24
7.5%
EPS (diluted)
HCM
HCM
MTUS
MTUS
Q4 25
$0.00
$-0.34
Q3 25
$0.19
Q2 25
$0.52
$0.09
Q1 25
$0.01
$0.03
Q4 24
$-0.46
Q3 24
$-0.13
Q2 24
$0.03
$0.10
Q1 24
$0.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
MTUS
MTUS
Cash + ST InvestmentsLiquidity on hand
$1.4B
$156.7M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$686.0M
Total Assets
$1.8B
$1.1B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
MTUS
MTUS
Q4 25
$1.4B
$156.7M
Q3 25
$191.5M
Q2 25
$1.4B
$190.8M
Q1 25
$836.1M
$180.3M
Q4 24
$240.7M
Q3 24
$254.6M
Q2 24
$802.5M
$272.8M
Q1 24
$278.1M
Total Debt
HCM
HCM
MTUS
MTUS
Q4 25
$93.2M
Q3 25
$0
Q2 25
$93.4M
$0
Q1 25
$82.8M
$5.4M
Q4 24
$5.4M
Q3 24
$13.2M
Q2 24
$82.1M
$13.2M
Q1 24
$13.2M
Stockholders' Equity
HCM
HCM
MTUS
MTUS
Q4 25
$1.2B
$686.0M
Q3 25
$697.7M
Q2 25
$1.2B
$690.0M
Q1 25
$759.9M
$686.1M
Q4 24
$690.5M
Q3 24
$712.7M
Q2 24
$740.1M
$736.3M
Q1 24
$739.3M
Total Assets
HCM
HCM
MTUS
MTUS
Q4 25
$1.8B
$1.1B
Q3 25
$1.2B
Q2 25
$1.8B
$1.1B
Q1 25
$1.3B
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.3B
$1.1B
Q1 24
$1.2B
Debt / Equity
HCM
HCM
MTUS
MTUS
Q4 25
0.08×
Q3 25
0.00×
Q2 25
0.08×
0.00×
Q1 25
0.11×
0.01×
Q4 24
0.01×
Q3 24
0.02×
Q2 24
0.11×
0.02×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
MTUS
MTUS
Operating Cash FlowLast quarter
$8.2M
$-1.9M
Free Cash FlowOCF − Capex
$3.4M
$-37.2M
FCF MarginFCF / Revenue
1.2%
-13.9%
Capex IntensityCapex / Revenue
1.8%
13.2%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$-93.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
MTUS
MTUS
Q4 25
$8.2M
$-1.9M
Q3 25
$22.0M
Q2 25
$-72.9M
$34.8M
Q1 25
$40.3M
$-38.9M
Q4 24
$13.9M
Q3 24
$-15.3M
Q2 24
$-39.8M
$8.3M
Q1 24
$33.4M
Free Cash Flow
HCM
HCM
MTUS
MTUS
Q4 25
$3.4M
$-37.2M
Q3 25
$-6.4M
Q2 25
$-82.2M
$17.0M
Q1 25
$32.5M
$-66.4M
Q4 24
$-1.3M
Q3 24
$-32.9M
Q2 24
$-49.9M
$-5.8M
Q1 24
$16.0M
FCF Margin
HCM
HCM
MTUS
MTUS
Q4 25
1.2%
-13.9%
Q3 25
-2.1%
Q2 25
-29.6%
5.6%
Q1 25
10.0%
-23.7%
Q4 24
-0.5%
Q3 24
-14.5%
Q2 24
-16.3%
-2.0%
Q1 24
5.0%
Capex Intensity
HCM
HCM
MTUS
MTUS
Q4 25
1.8%
13.2%
Q3 25
9.3%
Q2 25
3.3%
5.8%
Q1 25
2.4%
9.8%
Q4 24
6.3%
Q3 24
7.7%
Q2 24
3.3%
4.8%
Q1 24
5.4%
Cash Conversion
HCM
HCM
MTUS
MTUS
Q4 25
4.21×
Q3 25
2.72×
Q2 25
-0.16×
9.41×
Q1 25
3.38×
-29.92×
Q4 24
Q3 24
Q2 24
-1.54×
1.80×
Q1 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

MTUS
MTUS

Industrial Market Sector$95.3M36%
Manufactured Components$67.8M25%
Aerospace And Defense$39.6M15%
Seamless Mechanical Tubing$31.3M12%
Energy Market Sector$18.3M7%
Other$11.3M4%
Other Market Sector$3.7M1%

Related Comparisons